However, in our model, IGF-2 was undetectable in control livers, was highest in the sedentary 20-week CD-HFD group linked to the highest NAFLD score, and was significantly reduced in the exercised group (Figure 6C). The gene discussed is IGF2; the disease is metabolic dysfunction-associated steatotic liver disease.